Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

Presentation TCT 2017

Acute and Chronic Right-Sided Support

Presenter: Navin K. Kapur

November 01, 2017

Presentation TCT 2017

Syncardia: Progress With a Total Artificial Heart

Presenter: Francisco A Arabía

November 01, 2017

Presentation TCT 2017

Heart Assist 5: Continuous, Remote Flow Monitoring

Presenter: Valluvan Jeevanandam

November 01, 2017

Presentation TCT 2017

Heart Mate III: Has the Problem of Thrombus Been Solved?

Presenter: Nir Uriel

November 01, 2017

Presentation TCT 2017

HVAD/MVAD/CircuLite Update

Presenter: Daniel Burkhoff

November 01, 2017

Presentation TCT 2017

ENDURANCE of MOMENTUM: Destination Therapy State-of-the-Art

Presenter: Ulrich P. Jorde

November 01, 2017

Presentation TCT 2017

Aortic Arch Electrical Stimulation for Heart Failure

Presenter: Jozef Bartunek

November 01, 2017

Presentation TCT 2017

The Potential for Neuromodulation in Heart Failure

Presenter: Felix Mahfoud

November 01, 2017

Presentation TCT 2017

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

Presenter: Navin K. Kapur

November 01, 2017

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

Presentation TCT 2017

First of the Class: Tissue Engineering

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent

October 31, 2017

Presentation TCT 2017

New Strategies for a Chronic Scenario: Combinative Approaches

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Advertisement

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Acute and Chronic Right-Sided Support

Syncardia: Progress With a Total Artificial Heart

Heart Assist 5: Continuous, Remote Flow Monitoring

Heart Mate III: Has the Problem of Thrombus Been Solved?

HVAD/MVAD/CircuLite Update

ENDURANCE of MOMENTUM: Destination Therapy State-of-the-Art

Aortic Arch Electrical Stimulation for Heart Failure

The Potential for Neuromodulation in Heart Failure

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

First of the Class: Tissue Engineering

New Strategies for a Chronic Scenario: Combinative Approaches

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

New Targets: Heart Failure With Preserved Ejection Fraction

In Which Direction is Cell Based Heart Failure Therapy Headed?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content